1. Introduction
===============

In nature all living organisms react to unfavorable environmental conditions, such as high temperature, osmotic shock, oxidative damage and nutrient depletion via complex regulatory networks. These specific responses usually result from induction of a set of stress-associated genes whose expression is controlled by a common transcription factor. For example, in *Saccharomyces cerevisiae* a gene named *MSN2* that encodes a C~2~H~2~-type zinc-finger regulator, Msn2p, is required for yeast cells to cope with a broad range of environmental and physiological stresses \[[@B1-toxins-03-00082]\]. Msn2p mediates expression of a number of genes that are induced by stress conditions by binding to STRE ([st]{.ul}ress [r]{.ul}esponse [e]{.ul}lement) motifs, CCCCT, which are located in the promoters of the regulated genes \[[@B2-toxins-03-00082],[@B3-toxins-03-00082]\]. In *Trichoderma atrovirde* the expression of the *MSN2* ortholog *seb1*([s]{.ul}tress response [e]{.ul}lement [b]{.ul}inding) was increased under osmotic stress conditions \[[@B4-toxins-03-00082]\]. Seb1 functions to up-regulate the glycerol dehydrogenase gene (*gld1*) whose product, Gld1, is required for glycerol biosynthesis to alleviate osmotic stress \[[@B5-toxins-03-00082]\].

Conidiation and formation of sclerotia, hyphal aggregates that serve as the over-winter structure, are believed to be triggered by a hyperoxidant state (oxidative stress) in cells at late stages of fungal development \[[@B6-toxins-03-00082],[@B7-toxins-03-00082]\]. These processes are often interrelated with production of secondary metabolites, such as aflatoxins \[[@B8-toxins-03-00082],[@B9-toxins-03-00082],[@B10-toxins-03-00082]\] which may allow fungi to adapt to unique niches and life cycles. Jeon *et al.* \[[@B8-toxins-03-00082]\] showed that deletion of the *MSN2* ortholog (*msnA*) in *Aspergillus nidulans*resulted in enhanced asexual conidiation and production of sexual cleistothecia. Hence, they renamed the *A. nidulansmsnA* as *nrdA* ([n]{.ul}egative [r]{.ul}egulator of [d]{.ul}ifferentiation). Not all *Aspergillus* species have a natural sexual reproductive stage. *Aspergillus parasiticus* and *Aspergillus flavus*, the predominant producers of the aflatoxins, were thought, until recently, to possess only the asexual state, but under forced mating conditions in the laboratories strains of opposite mating types were able to undergo sexual reproduction \[[@B9-toxins-03-00082],[@B10-toxins-03-00082]\]. The majority of *A. parasiticus* strains produce abundant conidia, but some strains, in addition to conidia, also produce large numbers of sclerotia on the same media \[[@B11-toxins-03-00082]\]. *A. flavus* strains are morphologically diverse. Some strains produce predominantly conidia with a few large-sized sclerotia, and others produce copious tiny sclerotia along with a low number of conidia; the former is called L-strain and the latter S-strain \[[@B12-toxins-03-00082]\].

In this study, we investigated the role of *msnA* in two morphologically distinct *A. parasiticus*strains and an L-strain *A. flavus* isolate. Deletion of *msnA* adversely affected vegetative growth and altered development as manifested by dense conidiation and the lack of sclerotial formation. Expression of oxidative stress defense genes and the production of kojic acid (5-hydroxy-2-(hydroxymethyl)-4-pyrone), a free radical scavenger, increased significantly in the *A. parasiticus* ∆msnA strains. Compared to respective wild-type strains, the ∆msnA strains of *A. parasiticus* and *A. flavus* produced increased levels of reactive oxygen species.

2. Materials and Methods
========================

2.1. Fungal Strains and Media
-----------------------------

*Aspergillus parasiticus*BN9∆ku70 \[[@B13-toxins-03-00082]\] and RH∆ku70 \[[@B14-toxins-03-00082]\] and *A. flavus* CA14PTs∆pyrG \[[@B15-toxins-03-00082]\], a ∆ku70 strain sensitive to pyrithiamine, were the recipient strains used in the *msnA* gene knockout experiments. *A. parasiticus* BN9∆ku70 and *A. flavus* CA14PTs∆pyrG are aflatoxigenic and produce abundant conidia and a few sclerotia. RH∆ku70 accumulates *O*-methylsterigmatocystin (OMST) as the end product; it produces abundant sclerotia and conidia when grown in the dark. OMST-accumulating isolates have been found to account for about 2.6% of an *A. parasiticus* population in a southwestern Georgia peanut field \[[@B11-toxins-03-00082]\]. Potato Dextrose Agar (PDA; EMD Chemicals Inc., Darmstadt, Germany) was used for fungal growth and production of conidia and sclerotia for enumeration. The mixed cereal agar (MCA, 5% Gerber^®^ Mixed Grain Cereal, 1.5% agar) \[[@B16-toxins-03-00082]\] was also used to promote sclerotial production.

2.2. Construction of the *msnA* Disruption Vector
-------------------------------------------------

TheEST of the *A. flavus msnA* gene (NAFAE55TH) was identified initially from the *Aspergillus flavus* Gene Index database at The Institute for Genomic Research (TIGR) based on *S. cerevisiaeMSN2* and its homologue in *A. nidulans* (AN1652.2). The complete *A. flavus msnA* gene was subsequently obtained from the *Aspergillus* Comparative Database at Broad Institute (<http://www.broadinstitute.org/annotation/genome/aspergillus_group/MultiHome.html>). Restriction analysis of *A. flavus msnA*and flanking regions was carried out using the DNAMAN software (Lynnon Soft, Vandreuil, Quebec, Canada). The *msnA* disruption vector was constructed as follows: a 1.4-kb *msnA* 5' and coding region and a 0.7-kb coding region near the 3' end were amplified by PCR using primers msn5K: CTGTCTCCCGGTACCTTTGATCG and msn5P: GAGTATGCGCTGCAGCGCTGTCTC, and msn3P: GAGACAGCGCTGCAGCGCATACTC and msn3H: CGTGGGAAGCTTCATAGAGCAC, respectively. The PCR fragments after digestion were cloned sequentially into corresponding sites in pUC19. The 2.0-kb *A. oryzaeptr* selectable marker amplified from pPTR1 \[[@B17-toxins-03-00082]\] was cloned into the PstI site of the above construct. This disruption vector construct, msnDV, was linearized by HindIII and KpnI to release the portion of pUC19 prior to fungal transformation.

2.3. Generation of *msnA* Disruption Strains of *A. parasiticus* and A. flavus
------------------------------------------------------------------------------

Preparation of protoplasts, *ptr*-based fungal transformation and selection of mutants were performed as previously described for *A. parasiticus* and *A. flavus* \[[@B14-toxins-03-00082]\]. Homologous recombination is the primary event in fungi with the *ku70*-deficient background. The *msnA* gene disruption was confirmed by PCR with location-specific primers based on the expected genomic patterns generated by homologous recombination in the ∆ku70 genetic background. The primers used were P1: GACACAAGGTTCGTCGGTGACT and P2: GGTACTCGCGTCGCGATTA. PCR was carried out under the following conditions in a Perkin Elmer GeneAmp PCR System 2400. Twenty-five pmol of each primer and 10 ng genomic DNA were added to 25 μL Platinum Blue PCR Supermix (Invitrogen, Carlsbad, California, USA) and subject to 30 cycles consisting of denaturation at 94 °C for 30 s, annealing at 55 °C for 30 s and extension at 72 °C for 5 min.

2.4. Reintroduction of *msnA* into the *A. flavus* ∆msnA Strain
---------------------------------------------------------------

A genomic DNA fragment containing the full-length *msnA* gene including a 0.58 kb 5'UTR and a 0.24 kb 3'UTR was amplified by PCR using the Accuprime supermix (Invitrogen) with primers msn-E-pyrG, ATAGAATTCCCCGCGACTGTCCATTAGTC and msn-B-pyrG, ATAGGATCCTTTGTGAAGACCATGT. The PCR product was first cloned into the EcoR1 and BamH1 sites of pPG28 \[[@B18-toxins-03-00082]\]. The *A. nidulans*autonomously-replicating sequence in the 5.2 kb HindIII fragment from pHELP1 \[[@B19-toxins-03-00082]\] was cloned into the resulting construct. The circular plasmid was transformed into an *A. flavus* CA14∆msnA strain by the *pyrG*-based transformation protocol \[[@B15-toxins-03-00082]\].

2.5. Colony Growth, Conidial Production, and Sclerotial Formation
-----------------------------------------------------------------

The ∆msnA and the parental strains were point inoculated on PDA plates (100 × 15 mm) in triplicate and grown for five days at 30 °C for the determination of vegetative growth based on the colony diameter. For enumeration of conidia, two culture plugs were cored with Transfertube^®^ (Spectrum, Houston, Texas, USA) from each of the three seven-day-old replicate PDA plates. The plugs were placed in a microfuge tube containing 0.5 mL ethanol to kill conidia and then vortexed 2 min with a Disruption Genie apparatus (ZYMO RESEARCH, Orange County, California, USA). Each sample was diluted 100-fold with a 0.01% Triton solution, and conidia were counted two to four times using a hemocytometer. The calculated numbers were the total conidia from the two agar plugs. Strains were cultured on PDA and MCA plates at 30 °C for a week for sclerotial formation.

2.6. Ultraviolet-Visible (UV-Vis) Spectrophotometry and Fourier Transform Infrared (FTIR) Spectroscopy
------------------------------------------------------------------------------------------------------

The ∆msnA strains produced an unknown diffusible pigment on MCA plates not observed on PDA plates. The water-soluble orange pigment was isolated from 25 MCA plates inoculated with *A. parasiticus* BN9∆msnA. The frozen and thawed cultures were filtered through No. 4 paper (Whatman, Piscataway, New Jersey, USA) and the filtrate passed through a 33mm Millex GP 0.22 µ syringe filter (Millipore, Billerica, Massachusetts, USA). The filtrate was stirred overnight with Amberlite XAD-2 resin (Rohm and Haas, Philadelphia, Pennsylvania, USA). The pigment was eluted from the XAD-2 resin with MeOH, and the solvent was removed under reduced pressure. The remaining solids were dissolved in water and applied to a Sephadex G-25 column (GE Healthcare, Piscataway, New Jersey, USA). The column was eluted with water, and the orange band was collected and lyophilized yielding 44 mg of the pigment. The absorbance spectrum between 350 and 700 nm for the pigment dissolved in water was recorded on an Agilent 8453 photodiode array UV-Vis spectrophotometer (Agilent, Santa Clara, California, USA). Fourier Transform Infrared (FTIR) analysis, which provides information about the chemical bonding and the molecular structure of a compound, was performed. The infrared spectrum of the mixture of 0.5% of the orange pigment in KBr was obtained by diffuse reflectance on a Nicolet 6700 FTIR (Thermo Scientific, Waltham, Massachusetts, USA).

2.7. Determination of Aflatoxins and Kojic Acid by HPLC
-------------------------------------------------------

The amounts of aflatoxins and kojic acid produced on MCA plates in triplicate by four- and eight-day-old cultures of wild type and ∆msn strains of *A. parasiticus*BN9 (only kojic acid was determined for RH), and *A. flavus*CA14 were determined. For each sample, the entire contents of the Petri dish (100 × 15 mm, 25 mL per plate) were added to a Waring MC-2 blender cup and blended for 30 s with 20 mL hot water. The mixture was filtered through Whatman No. 4 paper and a 33 mm Millipore Millex GP 0.22μm syringe filter. The filtered extracts were analyzed for aflatoxins and kojic acid on a HPLC system (Agilent) consisting of a quaternary pump, autosampler, photodiode array detector, and fluorescence detector. The analyses were performed on a column of Intersil ODS-3, 5 μ, 4.6 × 250 mm (GL Sciences, Torrance, California, USA) at a flow rate of 1.0 mL/min. The injection volume was 20 μL. The mobile phase for aflatoxins was H~2~O:CH~3~CN:MeOH (45:25:30) and for kojic acid MeOH:0.1% H~3~PO~4~ (25:75), isocratic. Detection of aflatoxins was based on fluorescence at 365 nm excitation and 455 nm emission with "PHRED" postcolumn photochemical derivatization (Aura Industries, New York, New York, USA). Detection of kojic acid was based on UV absorption at 265 nm. The retention times of the standards for aflatoxins B~1~, B~2~, G~1~ and G~2~ were 10.6 min, 9.4 min, 8.7 min and 7.8 min, respectively, and for kojic acid the retention time was 5.4 min.

2.8. RNA Isolation and Probe Labeling
-------------------------------------

An aliquot of spore suspension was added to each Petri dish plate (100 × 15 mm) containing 30 mL potato dextrose broth (PDB, Merck, Darmstadt, Germany) to give a final concentration of 3 × 10^5^ spores per milliliter. Four dishes were used for each strain. Stationary cultures were incubated at 30 °C in the dark for 4 days. Harvested mycelium were pooled and rinsed with sterilized distilled water and pulverized to a fine powder with a mortar and pestle in the presence of liquid nitrogen. Total RNA was prepared using TRIzol^®^ reagent (Invitrogen) and treated with amplification grade DNase I followed by purification with an RNeasy Plant Mini kit (Qiagen, Valencia, California, USA).

Fluorescent dye Cy3 and Cy5 labeled probes were prepared using the indirect labeling method of aminoallyl-cRNA according to the protocol provided by TIGR. A total of 6 μg of aminoallyl-cRNA were needed in each probe labeling. The aminoallyl-cRNA was synthesized and amplified using an Amino Allyl MessageAmp™ II aRNA Amplification kit (Ambion, Austin, Texas, USA). Mono-reactive dyes Cy3 and Cy5 (Amersham, Piscataway, New Jersey, USA) were coupled respectively to aminoallyl-cRNA from wild type and mutant. The unincorporated free dyes were removed using the RNeasy MinElute cleanup kit (Qiagen).

2.9. Microarray Assays
----------------------

The microarray used was *Aspergillus flavus* NRRL3357 27.6k oligo array \[[@B20-toxins-03-00082]\]. A direct comparison design was applied, including Mutant/Wild type. Four technical replicates were used, including two dye swaps to compensate for cyanine dye effects. Following hybridization and washing according to the TIGR protocol, the microarray slides were scanned by a Genepix 4000B (Molecular Devices, Sunnyvale, California, USA), and the images were analyzed using GENEPIX 6.0 software.

Microarray data were normalized and analyzed using GeneSpring GX 10.0 software (Silicon Genetics, Redwood City, California, USA). Two criteria were used for selecting positive spots, (Signal-Background) mean \> 500 unit as expression intensity filter, and at least two of the four replicates showing positive. These filters were imposed to remove genes with very minor differential expression or genes with little evidence for expression. Data normalization was performed using local regression LOWESS (locally weighted scatterplot smoothing). Differentially expressed genes were identified by performing a one-way ANOVA on the normalized data using a T test with no assumption of equal variance. The cutoff criteria in fold change analysis were set as P \< 0.05 in significant difference and fold change \>2.

2.10. Quantitative PCR
----------------------

Quantitative real-time PCR (qPCR) was carried out in a 20-μL reaction volume with the SYBR Green Master Mix (Applied Biosystems, Foster City, California, USA) in a StepOne^TM^ thermal cycler (Applied Biosystems). PCR conditions were as follows: an initial step of 95 °C for 10 min and 40 cycles with each cycle consisting of 95 °C for 15 s and 60 °C for 1 min. The primers sets used were designed by the PrimerExpress 3.0 software following the guidelines specified by Applied Biosystems. The specificity of the PCR products was confirmed by the melt curve analysis. The relative expression levels of the genes examined were determined by the relative standard curve method, in which standard curves based on 5-point, 10-fold serial dilutions were constructed for the endogenous (18S) and the target gene in each experiment using genomic DNA as the template.

2.11. Quantification of Reactive Oxygen Species (ROS)
-----------------------------------------------------

ROS generation was assessed using the substrate 2',7'-dichlorofluorescein diacetate (DCFH-DA; Sigma D6883). Oxidation of non-fluorescent DCFH-DA by ROS, such as H~2~O~2~ and the hydroxyl radical, yields the fluorescent product dichlorofluorescin (DCF). DCF fluorescence spectra is usually measured using excitation/emission wavelength of 490/525 nm. In this study, we used the OneStepPlus qPCR instrument (Applied Biosystems) that is able to measure dye fluorescence with the program set for the detection of SYBR^®^-DNA complex at excitation/emission wavelength of 488/522 nm. DCFH-DA stock solution (100×, 1 mM in dimethyl formamide) was prepared. Four agar plugs were cored from each PDA culture plate grown for 7 days at 30 °C. They were placed into a microfuge tube, and 1mL freshly made 1× PBS containing DCFH-DA at a final concentration of 1 μM was added. The reaction was allowed to continue at 37 °C for specified time periods (1, 5 or 24 hr). At the end of each time period, three replicates of 30 μL from each sample were loaded into the optical 48-well reaction plate. The program was set to hold at 37 °C and fluorescence measurements were taken for 6 cycles at 10 min intervals.

3. Results
==========

3.1. Vegetative Growth, Conidial Production, and Sclerotial Formation of ∆msnA Strains
--------------------------------------------------------------------------------------

Disruption of *msnA* in *A. parasiticus* BN9 and RH, and *A. flavus* CA14 was confirmed by PCR based on expected genomic patterns ([Figure S1](#toxins-03-00082-s001){ref-type="fig"}). Colonies of the ∆msnA strains of *A. parasiticus* and *A. flavus* exhibited a restricted, densely-packed appearance on PDA plates. The radial colony growth of the ∆msnA strains was 2 to 3-fold less than that of the parental strains ([Figure 1](#toxins-03-00082-f001){ref-type="fig"}A). Compared to the parental strains the ∆msnA strains produced more conidia as estimated from an identical area ([Figure 1](#toxins-03-00082-f001){ref-type="fig"}B). The increase in conidiation of *A. parasiticus* BN9∆msnA (36%) was less than that of *A. parasiticus* RH∆msnA (\>600%) and *A. flavus* CA14∆msnA (84%). Although *A. parasiticus* RH is a strain that produces many sclerotia, RH∆msnA was unable to produce any on PDA; BN9∆msnA and CA14∆msnA were also unable to produce sclerotia on the same medium.

![Effect of *msnA* disruption on colony size and conidial production. (A) Colony size after growth for five days at 30 °C. (B) Conidial production estimated from two cored agar plugs (see Materials and Methods 2.5). The gray bar represents the wild-type strain, and the clear bar represents the ∆msnA strain. Ap: *A. parasiticus*; Af: *A. flavus*.](toxins-03-00082-g001){#toxins-03-00082-f001}

To further examine whether sclerotial formation of the three ∆msnA strains was abolished, we grew them on mixed cereal agar plates. All strains did not produce sclerotia on this medium either. They, however, produced a diffusible orange-colored substance that increased in intensity after prolonged incubation ([Figure 2](#toxins-03-00082-f002){ref-type="fig"}). In contrast, the orange-colored pigment was barely produced by the wild-type strains after the same 7-day period of growth.

3.2. Characterization of the Pigment by FTIR
--------------------------------------------

Based on the color we speculated that the orange pigment might be a complex derived from kojic acid, a metabolite commonly produced by some strains of *A. flavus* and closely related *A. oryzae*. The UV-Vis spectrum of the pigment purified from the *A. parasiticus* BN9∆msnA culture matched with the published spectrum of the complex of 3 kojic acid moieties per Fe(III) \[[@B21-toxins-03-00082]\] and had a peak absorbance at 398 nm and a broad shoulder at 460 nm ([Figure S2](#toxins-03-00082-s002){ref-type="fig"}). The kojic acid in the complex was confirmed by FTIR analysis using kojic acid as the reference. The separate FTIR spectra of kojic acid and the pigment are shown in [Figure 3](#toxins-03-00082-f003){ref-type="fig"}A. The overlaid image indicates that the two spectra are nearly identical ([Figure 3](#toxins-03-00082-f003){ref-type="fig"}B); two extra peaks in the carbonyl region (1,500 to 1,700 cm^−1^) appear in the pigment and another observed difference is at about 2,550 cm^−1^.

![Culture morphology of *A. parasiticus* and *A. flavus* strains on MCA plates. (A) wild-type *A. parasiticus*BN9 (B) *A. parasiticus* BN9∆msnA (C) wild-type *A. parasiticus* RH; the white granules around the edge of the colony are sclerotia (D)*A. parasiticus* RH∆msnA (E) wild-type *A. flavus*CA14 (F) *A. flavus* CA14∆msnA.](toxins-03-00082-g002){#toxins-03-00082-f002}

![Characterization of the orange pigment by FTIR. (A) Spectrum of kojic acid: top panel red-line and spectrum of the pigment isolated from *A. parasiticus* BN9∆msnA: bottom panel blue-line. (B) Overlaid spectra.](toxins-03-00082-g003){#toxins-03-00082-f003}

3.3. Production of Aflatoxins and Kojic Acid by the *∆msnA* Strains of *A. parasiticus* BN9 and A. flavus CA14
--------------------------------------------------------------------------------------------------------------

To determine how production of aflatoxins and kojic acid was affected by *msnA* disruption, we carried out a time-course quantitative determination. The normalized data (to growth area, [Table 1](#toxins-03-00082-t001){ref-type="table"}) showed that the production of total aflatoxins and kojic acid increased from day 4 to day 8 in the *parasiticus* BN9∆msnA strain. The ∆msnA strain accumulated 50% more aflatoxins and 20-fold more kojic acid than the parental strain at day 8. The *A. parasiticus* strain RH is a blocked strain that accumulates *O*-methylsterigmatocystin as the end product. Although it does not produce aflatoxins, the derived RH∆msnA strain produced 10-fold more kojic acid. The *A. flavus* CA14∆msnA strain produced only small amounts of aflatoxins, but it produced four-fold more kojic acid than the parental strain.

###### 

Production of aflatoxins and kojic acid by ∆msnA strains on MCA.

  Strain(T)^a^   Colony(mm)^b^   AF(μg)^c^          KA(mg)^c^                   
  -------------- --------------- ----------- ------ ----------- ------ -------- ------
  BN9(4)         42              2.87        0.09   4.50        0.09   7.58     0.06
  BN∆msn (4)     17              4.36        0.13   5.11        0.09   9.69     1.06
  BN9(8)         75              5.36        0.18   7.18        0.17   12.90    0.05
  BN∆msn (8)     28              9.31        0.31   10.04       0.24   19.81    1.19
  RH(4)          42                                                    ND^d^    0.10
  RH∆msn (4)     13                                                    ND       1.17
  RH(7)          67                                                    ND       0.12
  RH∆msn (8)     20                                                    ND       1.38
  CA14(4)        35              \<0.01                                \<0.01   0.18
  CA∆msn (4)     13              0.02                                  0.02     0.83
  CA14(8)        76              \<0.01                                \<0.01   0.35
  CA∆msn (8)     27              0.01                                  0.01     1.33

3.4. Microarray Profiling of Differentially Expressed Genes in the ∆msnA Strains of *A. parasiticus* and *A. flavus*
--------------------------------------------------------------------------------------------------------------------

Microarray assays identified many differentially expressed genes in the ∆msnA strains of *A. parasiticus* BN9 and *A. flavus*CA14 ([Table S1](#toxins-03-00082-s004){ref-type="supplementary-material"} and [Table S2](#toxins-03-00082-s005){ref-type="supplementary-material"}). For *A. parasiticus*, approximately 85% of the genes (0.005% saturation and 500 cutoff) were down-regulated; only 12 genes were up-regulated (°2-fold), and they included those oxidative stress defense genes encoding superoxide dismutase, catalase, and cytochrome c peroxidase. The up-regulation of these genes was confirmed by qPCR ([Table 2](#toxins-03-00082-t002){ref-type="table"}). For *A. flavus*, approximately two thirds of the genes profiled were down-regulated; the genes up-regulated were diverse including many of those encoding hypothetical proteins, and only one up-regulated catalase A gene for the *A. flavus* ∆msnA strain was found.

###### 

Expression of oxidative stress defense genes in *A. parasiticus* BN9∆msnA.

  Enzyme                    Gene Locus                Oligoprimer Sequence   Fold-of-Increase ^c^
  ------------------------- ------------------------- ---------------------- ----------------------
  superoxide dismutase      AFL2G_10810.2 ^a^         cgccggtactgacgacctt    2.09 ° 0.06
  AFLA_099000 ^b^           agcattgccagtcttcttgga                            
  catalase                  AFL2G_05806.2             caggtggcttcgcgtccta    2.30 ° 0.13
  AFLA_056170               caggccgcgcttcttg                                 
  cytochrome c peroxidase   AFL2G_04481.2             tcggtcgtgcccatcct      2.38 ° 0.12
  AFLA_110690               aagacagtagggctgaagttcca                          

3.5. ROS Production by *A. parasiticus* and *A. flavus* ∆msnA Strains and by *A. flavus msnA* Addback Strains
-------------------------------------------------------------------------------------------------------------

The recent generation of the *A. flavus* CA14-derived double mutant makes it possible to retransform a knockout strain, such as the ∆msnA strain, using a second selectable marker along with an intact gene to confirm gene function \[[@B15-toxins-03-00082]\]. By this approach, the defects in colony growth were remediated in the *A. flavus* CA14∆msnA strain after the intact *msnA* genomic DNA was reintroduced ([Figure S3](#toxins-03-00082-s003){ref-type="fig"}).

![Production of reactive oxygen species (ROS) by *A. parasiticus* and *A. flavus*strains. Solid bar: parental strain, clear bar: independent ∆msnA strains, and gray bar, independent msnA addback strains.](toxins-03-00082-g004){#toxins-03-00082-f004}

ROS production by the wild-type strains, ∆msnA strains of *A. parasiticus* and *A. flavus*, and by the *A. flavus*msnA addback strain was determined to see whether ROS levels correlated with observed changes in growth, development and secondary metabolite production. ROS production was found to fluctuate in the first 5 hr incubation assays (data not shown). Only after 24 hr incubation a more distinct pattern emerged; an increase in ROS production was seen in all ∆msnA strains ([Figure 4](#toxins-03-00082-f004){ref-type="fig"}). ROS production by the *A. flavus* msnA addback strains was decreased to levels comparable to that of the wild-type *A. flavus*.

4. Discussion
=============

Our results show that *msnA* is required for normal colony growth and development of *A. parasiticus* and *A. flavus*. Similar findings have been reported for *Trichoderma atrovidire* \[[@B4-toxins-03-00082]\] and *A. nidulans* \[[@B22-toxins-03-00082]\]. The role of oxidative stress in conidiation has been implicated in *A. nidulans* \[[@B23-toxins-03-00082]\]. Likewise, exposure of *Neurospora crassa* to antioxidants inhibits conidiation \[[@B24-toxins-03-00082]\]. The *N. crassa* catalase-3 gene mutant that was sensitive to hydrogen peroxide produced six-times more conidia \[[@B25-toxins-03-00082]\]. The increased production of conidia in the ∆msnA strains ([Figure 1](#toxins-03-00082-f001){ref-type="fig"}B) can be correlated with the increased levels of ROS ([Figure 4](#toxins-03-00082-f004){ref-type="fig"}) and suggests that conidiation is a response to increased levels of oxidative stress in the cells.

Sclerotial formation like conidiation has been correlated with oxidative stress, antioxidant effects, and antioxidant enzyme activities \[[@B26-toxins-03-00082],[@B27-toxins-03-00082]\]. Sclerotia of *A. parasiticus* and *A. flavus* are considered to be a vestige of the sexual cleistothecia produced by other aspergilli \[[@B28-toxins-03-00082]\]. The light responses of the two structures regulated by the common factor VeA \[[@B29-toxins-03-00082],[@B30-toxins-03-00082],[@B31-toxins-03-00082]\] are similar. In the dark *A. nidulans* favors the formation of cleistothecia \[[@B32-toxins-03-00082],[@B33-toxins-03-00082]\], and under light *A. parasiticus* and *A. flavus* suppress sclerotial production \[[@B34-toxins-03-00082]\]. The ∆msnA strains of *A. parasiticus* and *A. flavus* are unable to produce sclerotia. This result was unexpected since the *A. nidulans nrdA*(*msnA*)-null strain produced enhanced levels of cleistothecia \[[@B22-toxins-03-00082]\]. It suggests that subtle differences likely exist in the regulation of sclerotial and cleistothecial morphogenesis. Impairment of *msnA* like the disruption of *laeA*, a secondary metabolism regulatory gene \[[@B35-toxins-03-00082]\], abolishes sclerotial formation but not conidiation, which shows that the two developmental processes are regulated differently.

Aflatoxin biosynthesis may be a defense mechanism against oxidative stress \[[@B36-toxins-03-00082],[@B37-toxins-03-00082],[@B38-toxins-03-00082]\]. Studies have demonstrated that natural antioxidants, such as gallic acid, caffeic acid and eugenol can reduce aflatoxin production \[[@B39-toxins-03-00082],[@B40-toxins-03-00082],[@B41-toxins-03-00082]\]. Several lines of evidence also have suggested a positive correlation between ROS accumulation and aflatoxin production by *A. flavus* and *A. parasiticus* \[[@B36-toxins-03-00082],[@B42-toxins-03-00082]\]. Deletion of the *A. parasiticus yapA* gene, which encodes a transcription factor that mediates oxidative stress response, resulted in precocious ROS formation and increased aflatoxin biosynthesis \[[@B38-toxins-03-00082]\]. Supporting this correlation we found that compared to respective parental strains, the ∆msnA strains produced more aflatoxins ([Table 1](#toxins-03-00082-t001){ref-type="table"}) and had higher levels of ROS accumulation ([Figure 4](#toxins-03-00082-f004){ref-type="fig"}). Beside aflatoxins, FTIR assays confirm that the orange pigment is a kojic acid-iron complex ([Figure 3](#toxins-03-00082-f003){ref-type="fig"}). The peaks at 1500 and 1580 cm^−1^ in the spectrum of the pigment are consistent with the chelation of kojic acid with a metal through the carbonyl moiety ([Figure 3](#toxins-03-00082-f003){ref-type="fig"}B). Kojic acid is a scavenger of free radicals \[[@B43-toxins-03-00082]\]. The highly elevated production levels ([Table 1](#toxins-03-00082-t001){ref-type="table"}) suggest that the ∆msnA strains use the formation of kojic acid as a main detoxifying mechanism.

Microarray comparisons of ∆msnA to wild-type showed that genes encoding superoxide dismutase, catalase, and cytochrome c peroxidase in the *A. parasiticus* BN9∆msnA strain were up-regulated ([Table 2](#toxins-03-00082-t002){ref-type="table"}). The result suggests that expression of these genes is probably needed to cope with increased oxidative stress in the cells. The generation of ROS is potentially deleterious. Superoxide dismutase converts superoxide to another ROS, hydrogen peroxide, probably to shunt the superoxide away from harmful lipid peroxidation to the cells \[[@B44-toxins-03-00082]\] or from damages to DNA \[[@B45-toxins-03-00082]\]. Catalase converts hydrogen peroxide to water and oxygen molecule. Like catalase, cytochrome c peroxidase takes reducing equivalents from cytochrome c and converts hydrogen peroxide to water. Different types of oxidative stress defense genes operate in the ∆msnA strains of *A. parasiticus* and *A. flavus*; this likely reflects respective physiological responses of each species in spite of their close genetic relatedness. The varied amounts of aflatoxins and/or kojic acid produced by respective ∆msnA strains also reflect intrinsic differences of the two species and within members of the same species, such as BN9 and RH.

5. Conclusions
==============

This study suggests that the ∆msnA strains of *A. parasiticus* and *A. flavus* are not as capable as the wild-type strains in relieving oxidative stress and respond by up-regulating antioxidant enzyme genes as well as by increasing the production of conidia, aflatoxins, and kojic acid to alleviate the increased oxidative stress caused by the loss of *msnA*.

Supplementary Materials
=======================

![Disruption of the *msnA* gene in *A. parasiticus* and *A. flavus* by the *ptr* selectable marker. (A) Diagram depicting the gene disruption event via double-crossover recombination. I: linearized portion of the disruption vector; II: genomic pattern of the recipient strain; III: expected genomic pattern after recombination. (B) PCR confirmation of genomic DNA patterns of the recipient, R, and the *msnA* disruptant, D. The primers used were P1 and P2. The DNA size markers (in kb) are lambda DNA/Hind III fragments. The three sets are 1: *A. parasiticus* BN9, 2: *A parasiticus* RH and 3: *A. flavus* CA14.](toxins-03-00082-s001){#toxins-03-00082-s001}

![Characterization of the orange pigment by ultraviolet-visible spectrophotometry. (A) Structure of the 3kojic acid-ferric iron (Fe^+3^) complex. (B) UV-Vis spectrum of the orange pigment.](toxins-03-00082-s002){#toxins-03-00082-s002}

![Colony morphology of *A. flavus* CA14∆msnA retransformed with the genomic *msnA* gene. Left: wild type, middle: CA14∆msnA, and right: msnA addback transformant. Cultures were grown at 30 °C for a week in the dark on PDA plates.](toxins-03-00082-s003){#toxins-03-00082-s003}

###### 

Genes differentially expressed in *A. parasiticus*BN9∆msnA.

  Gene ID (a)      Fold change   Regulation   Annotation
  ---------------- ------------- ------------ ---------------------------------------------------------------------------
  AFLA_003050      2.13          down         RTA1 like protein
  AFLA_003050      2.12          down         RTA1 like protein
  AFLA_003090      2.10          down         hypothetical protein
  AFLA_004690      2.12          up           hypothetical protein
  AFLA_004690      2.21          up           hypothetical protein
  AFLA_004940      8.07          down         Glycolipid 2-alpha-mannosyltransferase family protein
  AFLA_005520      3.38          down         hypothetical protein
  AFLA_006160      2.90          down         hypothetical protein
  AFLA_011970      2.22          down         Major Facilitator Superfamily protein
  AFLA_014260      3.08          up           hydrophobin, putative
  AFLA_014960      2.73          down         hypothetical protein
  AFLA_015300      2.03          down         FMN-dependent dehydrogenase family protein
  AFLA_015300      2.43          down         FMN-dependent dehydrogenase family protein
  AFLA_015550      4.26          down         Sugar transporter family protein
  AFLA_015780      5.24          down         small oligopeptide transporter, OPT family protein
  AFLA_017860      2.00          up           hypothetical protein
  AFLA_024250      2.01          up           Amidase family protein
  AFLA_027340      2.04          down         Aha1 domain family, putative
  AFLA_027340      2.16          down         Aha1 domain family, putative
  AFLA_028030      3.03          down         conserved hypothetical protein
  AFLA_029390      4.22          down         HMG box family protein
  AFLA_036040      2.18          down         mitochondrial inner membrane translocase subunit (TIM17), putative
  AFLA_036040      2.23          down         mitochondrial inner membrane translocase subunit (TIM17), putative
  AFLA_036980      2.76          down         MOSC N-terminal beta barrel domain containing protein
  AFLA_037160      2.40          up           thiazole biosynthesis enzyme, putative
  AFLA_037160      2.29          up           thiazole biosynthesis enzyme, putative
  AFLA_037290      2.10          down         hypothetical protein
  AFLA_037290      5.14          down         hypothetical protein
  AFLA_040140      2.02          down         Major intrinsic protein
  AFLA_040400      6.62          down         hypothetical protein
  AFLA_041930      2.93          down         conserved hypothetical protein
  AFLA_042970      3.98          down         MIF4G domain containing protein
  AFLA_042970      5.44          down         MIF4G domain containing protein
  AFLA_046230      4.20          down         amino acid permease (Dip5), putative
  AFLA_046400      4.57          down         unknown-related
  AFLA_046400      4.41          down         DUF788 domain protein
  AFLA_051570      3.88          down         To ribosomal protein YmL36 precursormitochondrial
  AFLA_052640      2.07          down         PH domain containing protein
  AFLA_056170      2.10          up           mycelial catalase Cat1, putative
  AFLA_056170      2.05          up           mycelial catalase Cat1, putative
  AFLA_056480      2.91          down         glycosyl transferase, group 2 family protein
  AFLA_056480      3.85          down         glycosyl transferase, group 2 family protein
  AFLA_057950      2.50          up           hypothetical protein
  AFLA_057950      2.33          up           hypothetical protein
  AFLA_059660      2.38          down         Major intrinsic protein
  AFLA_060050      3.07          down         Amino acid permease family protein
  AFLA_060050      3.99          down         Amino acid permease family protein
  AFLA_060090      3.87          down         Major Facilitator Superfamily protein
  AFLA_068610      2.92          down         hypothetical protein
  AFLA_070900      3.43          down         hypothetical protein
  AFLA_073580      2.96          down         cell division control protein Cdc6, putative
  AFLA_073800      2.07          up           short chain dehydrogenase/reductase family, putative
  AFLA_073800      2.10          up           short chain dehydrogenase/reductase family, putative
  AFLA_076860      2.38          down         MOSC domain containing protein
  AFLA_080910      2.98          down         hypothetical protein
  AFLA_080910      2.65          down         hypothetical protein
  AFLA_085250      2.03          down         RNA recognition motif. (a.k.a. RRM, RBD, or RNP domain) protein, putative
  AFLA_087740      3.09          down         ANTH domain containing protein
  AFLA_089240      2.98          down         Amidase family protein
  AFLA_089240      3.09          down         Amidase family protein
  AFLA_091600      3.23          down         nascent polypeptide-associated complex (NAC) subunit, putative
  AFLA_091980      4.26          down         Ctr copper transporter family protein
  AFLA_091980      3.38          down         Ctr copper transporter family protein
  AFLA_092600      2.54          down         hypothetical protein
  AFLA_094470      2.58          down         To UV radiation resistance associated protein p63
  AFLA_096520      2.11          down         hypothetical protein
  AFLA_096570      4.88          down         hypothetical protein
  AFLA_097790      2.15          down         To chloride-bicarbonate anion exchanger AE2, putative
  AFLA_098050      3.28          down         gamma-cysteine synthetase regulatory subunit, putative
  AFLA_099000      2.07          up           Cu, Zn superoxide dismutase SOD1, putative
  AFLA_106370      2.46          down         Conserved hypothetical ATP binding protein
  AFLA_110690      2.04          up           Peroxidase family protein
  AFLA_110690      2.03          up           Peroxidase family protein
  AFLA_111740      2.83          down         To SAC1 protein, putative
  AFLA_111740      3.30          down         To SAC1 protein, putative
  AFLA_112180      2.50          down         ATP-dependent RNA helicase, putative
  AFLA_112420      2.59          down         hypothetical protein
  AFLA_112540      4.63          down         hypothetical protein
  AFLA_112540      5.17          down         hypothetical protein
  AFLA_114570      3.92          down         conserved hypothetical protein
  AFLA_118050      2.31          down         POT family protein
  AFLA_118050      2.47          down         POT family protein
  AFLA_119430      2.07          down         Sec1 family protein
  AFLA_120960      2.50          down         hypothetical protein
  AFLA_122110      2.32          up           bifunctional catalase-peroxidase Cat2
  AFLA_123290      3.12          down         hypothetical protein
  AFLA_123290      2.35          down         hypothetical protein
  AFLA_124420      2.32          down         amine oxidase, flavin-containing family protein
  AFLA_127570      3.63          down         hypothetical protein
  AFLA_128560      3.84          down         PrnA protein, putative
  AFLA_131410      3.93          down         PCI domain containing protein
  AFLA_132310      2.45          down         tRNA intron endonuclease, catalytic C-terminal domain containing protein
  AFLA_132310      3.58          down         tRNA intron endonuclease, catalytic C-terminal domain containing protein
  AFLA_132750      2.47          down         conserved hypothetical protein
  AFLA_133810      3.05          down         conserved hypothetical protein
  AFLA_137510      4.23          down         Emopamil binding protein
  AFLA_138590      2.01          up           cysteine-type peptidase, putative
  AO090012000538   2.90          down         predicted protein
  AO090012000538   2.45          down         predicted protein

###### 

Genes differentially expressed in *A. flavus*CA14∆msnA.

  Gene ID          Fold change   Regulation   Annotation
  ---------------- ------------- ------------ -------------------------------------------------------------------------------------------------------------------
  AFLA_001010      4.06          up           hypothetical protein
  AFLA_002840      3.43          down         conserved hypothetical protein
  AFLA_002840      4.83          down         conserved hypothetical protein
  AFLA_002860      2.62          down         Oxidoreductase family, NAD-binding Rossmann fold containing protein
  AFLA_002940      2.43          down         Glycosyl hydrolase family 76 protein
  AFLA_003980      2.51          down         cation diffusion facilitator family transporter containing protein
  AFLA_003980      2.38          down         cation diffusion facilitator family transporter containing protein
  AFLA_004420      2.22          up           hypothetical protein
  AFLA_007830      2.85          up           hypothetical protein
  AFLA_007830      3.00          up           hypothetical protein
  AFLA_007860      2.09          up           Major Facilitator Superfamily protein
  AFLA_007860      2.12          up           Major Facilitator Superfamily protein
  AFLA_010180      2.42          up           hypothetical protein
  AFLA_010180      2.35          up           hypothetical protein
  AFLA_011370      2.17          up           hypothetical protein
  AFLA_011370      2.23          up           hypothetical protein
  AFLA_011530      5.11          up           hypothetical protein
  AFLA_011530      5.76          up           hypothetical protein
  AFLA_011560      2.49          up           Phosphoesterase family protein
  AFLA_011560      2.43          up           Phosphoesterase family protein
  AFLA_012030      2.10          down         DUF895 domain membrane protein, putative
  AFLA_012030      2.08          down         DUF895 domain membrane protein, putative
  AFLA_012050      2.68          down         *N*-acetylglucosamine-6-phosphate deacetylase family protein
  AFLA_012050      2.47          down         *N*-acetylglucosamine-6-phosphate deacetylase family protein
  AFLA_012080      2.74          down         glucosamine-6-phosphate deaminase, putative
  AFLA_012080      2.74          down         glucosamine-6-phosphate deaminase, putative
  AFLA_013060      2.88          down         expressed protein, putative
  AFLA_013060      2.83          down         expressed protein, putative
  AFLA_013740      2.46          up           acid phosphatase SurE family protein
  AFLA_013740      2.45          up           acid phosphatase SurE family protein
  AFLA_014210      3.22          down         Major Facilitator Superfamily protein
  AFLA_014210      3.78          down         Major Facilitator Superfamily protein
  AFLA_014510      4.89          down         Formate/nitrite transporter family protein
  AFLA_014510      4.33          down         Formate/nitrite transporter family protein
  AFLA_015780      4.29          down         small oligopeptide transporter, OPT family protein
  AFLA_015780      3.91          down         small oligopeptide transporter, OPT family protein
  AFLA_015800      2.25          down         conserved hypothetical protein
  AFLA_017750      3.37          down         conserved hypothetical protein
  AFLA_017750      2.75          down         conserved hypothetical protein
  AFLA_018790      3.16          down         nitrate transporter (nitrate permease), putative
  AFLA_018790      3.21          down         nitrate transporter (nitrate permease), putative
  AFLA_019510      2.60          up           conserved hypothetical protein
  AFLA_019510      3.04          up           conserved hypothetical protein
  AFLA_021000      2.16          down         conserved hypothetical protein
  AFLA_022370      2.08          down         hypothetical protein
  AFLA_023610      3.94          down         hypothetical protein
  AFLA_025130      4.27          up           To blastomyces yeast phase-specific protein 1
  AFLA_025960      2.26          down         Nucleoside transporter family protein
  AFLA_025960      2.10          down         Nucleoside transporter family protein
  AFLA_026950      2.05          down         acetyl-CoA-acetyltransferase, putative
  AFLA_026950      2.22          down         acetyl-CoA-acetyltransferase, putative
  AFLA_028830      2.30          up           FG-GAP repeat family protein
  AFLA_028830      2.45          up           FG-GAP repeat family protein
  AFLA_028950      2.41          down         Glycosyl hydrolase family 81 protein
  AFLA_029000      2.03          up           hypothetical protein
  AFLA_029000      2.05          up           hypothetical protein
  AFLA_029970      3.69          down         conserved hypothetical protein
  AFLA_029970      3.51          down         conserved hypothetical protein
  AFLA_031380      3.64          down         class V chitinase, putative
  AFLA_031380      3.82          down         class V chitinase, putative
  AFLA_034140      3.10          down         Major Facilitator Superfamily protein
  AFLA_034140      2.88          down         Major Facilitator Superfamily protein
  AFLA_036370      2.37          down         phosphoenolpyruvate carboxykinase (ATP), putative
  AFLA_036370      2.24          down         phosphoenolpyruvate carboxykinase (ATP), putative
  AFLA_037820      3.75          up           Hsp20/alpha crystallin family protein
  AFLA_037820      3.81          up           Hsp20/alpha crystallin family protein
  AFLA_040140      2.07          down         Major intrinsic protein
  AFLA_040330      4.54          down         Chitin binding Peritrophin-A domain containing protein
  AFLA_040330      4.58          down         Chitin binding Peritrophin-A domain containing protein
  AFLA_041010      2.16          up           hypothetical protein
  AFLA_041010      2.16          up           hypothetical protein
  AFLA_041180      7.25          down         hypothetical protein
  AFLA_042000      2.01          down         D-isomer specific 2-hydroxyacid dehydrogenase family protein, putative
  AFLA_042360      2.07          up           hypothetical protein
  AFLA_042360      2.01          up           hypothetical protein
  AFLA_042540      2.38          up           hypothetical protein
  AFLA_043390      2.26          down         hypothetical protein
  AFLA_043390      2.13          down         hypothetical protein
  AFLA_044040      3.66          down         hypothetical protein
  AFLA_044720      3.39          down         permease, cytosine/purines, uracil, thiamine, allantoin family protein
  AFLA_044720      3.37          down         permease, cytosine/purines, uracil, thiamine, allantoin family protein
  AFLA_046620      2.91          up           MAPEG family protein
  AFLA_046620      2.66          up           MAPEG family protein
  AFLA_049470      3.22          up           hypothetical protein
  AFLA_049470      3.36          up           hypothetical protein
  AFLA_050070      2.19          down         conserved hypothetical protein
  AFLA_050940      2.08          down         phenylalanyl-tRNA synthetase, beta subunit, putative
  AFLA_053700      2.07          up           hypothetical protein
  AFLA_055550      2.75          down         conserved hypothetical protein
  AFLA_055550      2.55          down         conserved hypothetical protein
  AFLA_058030      2.77          down         MFS transporter, putative
  AFLA_058030      2.81          down         MFS transporter, putative
  AFLA_060260      2.32          up           heat shock protein HSP30, putative
  AFLA_062460      2.46          down         non-classical export protein (Nce2), putative
  AFLA_062460      2.66          down         non-classical export protein (Nce2), putative
  AFLA_063260      3.03          down         Sic1.20-related
  AFLA_063260      3.08          down         Sic1.20-related
  AFLA_063290      3.92          down         hypothetical protein
  AFLA_063290      4.09          down         hypothetical protein
  AFLA_063320      3.34          down         hypothetical protein
  AFLA_063320      3.74          down         hypothetical protein
  AFLA_065220      4.99          up           hypothetical protein
  AFLA_065220      4.93          up           hypothetical protein
  AFLA_065450      3.37          down         Deuterolysin metalloprotease, putative
  AFLA_065450      3.01          down         Deuterolysin metalloprotease, putative
  AFLA_065460      6.03          down         hypothetical protein
  AFLA_065460      7.02          down         hypothetical protein
  AFLA_065960      3.05          up           fucose-specific lectin, putative
  AFLA_065960      3.02          up           fucose-specific lectin, putative
  AFLA_066810      4.31          up           To blastomyces yeast phase-specific protein 1
  AFLA_067640      2.15          down         alternative NADH-dehydrogenase, putative
  AFLA_067640      2.18          down         alternative NADH-dehydrogenase, putative
  AFLA_067770      2.62          down         PQ loop repeat family protein
  AFLA_067770      2.64          down         PQ loop repeat family protein
  AFLA_068600      2.89          down         ammonium transporter MEAA, putative
  AFLA_068600      2.90          down         ammonium transporter MEAA, putative
  AFLA_068790      2.23          down         adenylylsulfate kinase, putative
  AFLA_068790      2.27          down         adenylylsulfate kinase, putative
  AFLA_070070      2.09          up           hypothetical protein
  AFLA_070070      2.07          up           hypothetical protein
  AFLA_070470      2.02          up           hypothetical protein
  AFLA_074060      2.40          down         R3H domain containing protein
  AFLA_075190      2.96          down         conserved hypothetical protein
  AFLA_075190      2.94          down         conserved hypothetical protein
  AFLA_078210      2.37          down         membrane protein-related
  AFLA_078210      2.36          down         membrane protein-related
  AFLA_078900      3.11          down         Glycosyl hydrolase family 20, catalytic domain containing protein
  AFLA_078900      2.70          down         Glycosyl hydrolase family 20, catalytic domain containing protein
  AFLA_083890      2.60          up           oxidoreductase, zinc-binding dehydrogenase family protein
  AFLA_083890      2.59          up           oxidoreductase, zinc-binding dehydrogenase family protein
  AFLA_087630      2.96          down         alpha, alpha-trehalose-phosphate synthase subunit, putative
  AFLA_087630      2.36          down         alpha, alpha-trehalose-phosphate synthase subunit, putative
  AFLA_087750      2.96          down         isopentenyl-diphosphate delta-isomerase, putative
  AFLA_090690      2.25          up           catalase A, putative
  AFLA_090690      2.73          up           catalase A, putative
  AFLA_090970      2.24          down         conserved hypothetical protein
  AFLA_090970      2.09          down         conserved hypothetical protein
  AFLA_091260      2.08          down         acetyltransferase, GNAT family protein
  AFLA_091260      2.15          down         acetyltransferase, GNAT family protein
  AFLA_094630      2.11          down         hypothetical protein
  AFLA_094630      2.16          down         hypothetical protein
  AFLA_095460      2.39          down         PBS lyase HEAT-like repeat family protein
  AFLA_098380      3.39          down         conidial hydrophobin RodA, putative
  AFLA_098380      3.77          down         conidial hydrophobin RodA, putative
  AFLA_098700      2.54          down         oxidoreductase, short chain dehydrogenase/reductase family protein
  AFLA_098700      2.47          down         oxidoreductase, short chain dehydrogenase/reductase family protein
  AFLA_099050      3.83          down         hypothetical protein
  AFLA_099050      3.70          down         hypothetical protein
  AFLA_101780      2.41          down         Oxidoreductase molybdopterin binding domain containing protein
  AFLA_101780      2.20          down         Oxidoreductase molybdopterin binding domain containing protein
  AFLA_101800      3.81          down         Glycosyl hydrolases family 18 protein
  AFLA_101800      4.33          down         Glycosyl hydrolases family 18 protein
  AFLA_104350      8.01          down         Dynamin central region family protein
  AFLA_104350      6.90          down         Dynamin central region family protein
  AFLA_105630      3.94          up           Cytochrome P450 family protein
  AFLA_105630      3.82          up           Cytochrome P450 family protein
  AFLA_109030      3.01          down         To nucleotide exsicion repair protein RAD7
  AFLA_109160      3.31          down         isopentenyl-diphosphate delta-isomerase, putative
  AFLA_110040      5.26          down         blr7677-related
  AFLA_110040      6.41          down         blr7677-related
  AFLA_112720      2.26          down         diphosphomevalonate decarboxylase, putative
  AFLA_112910      2.85          up           hypothetical protein
  AFLA_112910      2.89          up           hypothetical protein
  AFLA_113790      2.78          down         hypothetical protein
  AFLA_113790      2.39          down         hypothetical protein
  AFLA_115930      3.40          up           hypothetical protein
  AFLA_115930      3.22          up           hypothetical protein
  AFLA_119340      2.12          up           Helix-loop-helix DNA-binding domain containing protein
  AFLA_119340      2.29          up           Helix-loop-helix DNA-binding domain containing protein
  AFLA_125770      3.03          down         hypothetical protein
  AFLA_125770      3.25          down         hypothetical protein
  AFLA_127620      7.70          down         New cDNA-based gene: (AO_CDS_042706, novel, updateIDs: 11597, \[gene: novel_gene_1223, model: novel_model_1223\])
  AFLA_127620      11.51         down         New cDNA-based gene: (AO_CDS_042706, novel, updateIDs: 11597, \[gene: novel_gene_1223, model: novel_model_1223\])
  AFLA_129810      3.08          down         cytoplasmic asparaginyl-tRNA synthetase, putative
  AFLA_129810      2.94          down         cytoplasmic asparaginyl-tRNA synthetase, putative
  AFLA_130150      2.02          down         NAD+ dependent glutamate dehydrogenase, putative
  AFLA_133830      2.02          down         oxidoreductase, zinc-binding dehydrogenase family protein
  AFLA_134420      2.02          up           Sugar transporter family protein
  AFLA_139270      2.28          up           aflNa/ hypD/ hypothetical protein
  AFLA_139270      2.37          up           aflNa/ hypD/ hypothetical protein
  AFLA_139290      3.06          up           aflMa/ hypE/ hypothetical protein
  AFLA_139400      2.17          up           aflCa/hypC/hypothetical protein
  AFLA_139400      2.03          up           aflCa/hypC/hypothetical protein
  AO090120000447   6.76          down         predicted protein
  AO090120000447   5.18          down         predicted protein
